Alarmins: Chemotactic activators of immune responses

Current Opinion in Immunology

Volumn 17, Issue 4 SPEC. ISS., 2005, Pages 359-365

  Oppenheim, Joost J ^a   Yang, De ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; CATHELICIDIN; DEFENSIN; EOSINOPHIL PROTEIN X; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOSTIMULATING AGENT; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ANTIMICROBIAL ACTIVITY; CELL ACTIVATION; CHEMOTAXIS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; MOLECULAR INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; TISSUE INJURY;

EID: 20544442905     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.06.002     Document Type: Review

References (53)

1. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
2. A. Lanzavecchia, and F. Sallusto The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics Curr Opin Immunol 13 2001 291 298
3. T. Ganz Defensins: antimicrobial peptides of innate immunity Nat Rev Immunol 3 2003 710 720
4. M. Zanetti Cathelicidins, multifunctional peptides of the innate immunity J Leukoc Biol 75 2004 39 48
5. D. Yang, A. Biragyan, D.M. Hoover, J. Lubkowski, and J.J. Oppenheim Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense Annu Rev Immunol 22 2004 181 215 An overall review of the structures and diverse activities of antimicrobial pepides and proteins.
6. V. Nizet, T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R.A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R.L. Gallo Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 414 2001 454 457
7. C.L. Wilson, A.J. Ouellette, D.P. Satchell, T. Ayabe, Y.S. Lopez-Boado, J.L. Stratman, S.J. Hultgren, L.M. Matrisian, and W.C. Parks Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 1999 113 117
8. N.H. Salzman, D. Ghosh, K.M. Huttner, Y. Paterson, and C.L. Bevins Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin Nature 422 2003 522 526 Transgenic expression of human intestinal defensin at physiological levels protected mice against lethal intestinal infection with Salmonella typhimurium, demonstrating the direct in vivo antimicrobial effect of a single human defensin.
9. U. Andersson, H. Erlandsson-Harris, H. Yang, and K.J. Tracey HMGB1 as a DNA-binding cytokine J Leukoc Biol 72 2002 1084 1091
10. A. Di Nardo, A. Vitiello, and R.L. Gallo Cutting Edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide J Immunol 170 2003 2274 2278
11. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
12. •], this paper demonstrated for the first time, the capacity of high mobility group box protein 1 (HMGB1) to activate dendritic cells and to enhance humoral and cellular antigen-specific immune responses.
13. A.Y. Liu, D. Destoumieux, A.V. Wong, C.H. Park, E.V. Valore, L. Liu, and T. Ganz Human β-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation J Invest Dermatol 118 2002 275 281
14. •].
15. J.R. Garcia, A. Krause, S. Schulz, F.J. Rodriguez-Jimenez, E. Kluver, K. Adermann, U. Forssmann, A. Frimpong-Boateng, R. Bals, and W.G. Forssmann Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity FASEB J 15 2001 1819 1821
16. •], demonstrated that IL-17 and IL-22, two interleukins almost exclusively produced by activated T cells, markedly upregulated the expression of β-defensins by epithelial cells and keratinocytes, illustrating a positive feedback of adaptive immunity on innate immunity.
17. C.J. Hertz, Q. Wu, E.M. Porter, Y.J. Zhang, K.H. Weismuller, P.J. Godowski, T. Ganz, S.H. Randell, and R.L. Modlin Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β defensin-2 J Immunol 171 2003 6820 6826
18. R.A. Dorschner, V.K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G.H. Gudmundsson, and R.L. Gallo Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus J Invest Dermatol 117 2001 91 97
19. D. Yang, Q. Chen, H.F. Rosenberg, S.M. Rybak, D.L. Newton, Z.Y. Wang, Q. Fu, V.T. Tchernev, M. Wang, and B. Schweitzer Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation J Immunol 173 2004 6134 6142 Eosinophil-derived neurotoxin (EDN) induced dendritic cell (DC) cytokine production and maturation, demonstrating the capacity of EDN to activate DCs.
20. T. Bonaldi, F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M.E. Bianchi Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO J 22 2003 5551 5560 This is the first demonstration that the secretion of high mobility group box protein 1 (HMGB1) by monocytes/macrophages requires several sequential steps including hyperacetylation, translocation to the cytosol, and packaging into secretory lysosomes.
21. G. Chen, J. Li, M. Ochani, B. Rendon-Mitchell, X. Qiang, S. Susarla, L. Ulloa, H. Yang, S. Fan, and S.M. Goyert Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms J Leukoc Biol 76 2004 994 1001
22. H. Wang, H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, C. Metz, E.J. Miller, and K.J. Tracey Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat Med 10 2004 1216 1221 Cholinergic agonists suppressed macrophage release of high mobility group box protein 1 (HMGB1) via down-regulation of NF-κB activation in vitro and attenuated sepsis by lowering serum HMGB1 levels in vivo, establishing a physiological mechanism of inhibiting HMGB1 secretion.
23. B. Rendon-Mitchell, M. Ochani, J. Li, J. Han, H. Wang, H. Yang, S. Susarla, C. Czura, R.A. Mitchell, and G. Chen IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J Immunol 170 2003 3890 3897
24. C.X. Zhou, Y.L. Zhang, L. Xiao, M. Zheng, K.M. Leung, M.Y. Chan, P.S. Lo, L.L. Tsang, H.Y. Wong, and L.S. Ho An epididymis-specific β-defensin is important for the initiation of sperm maturation Nat Cell Biol 6 2004 458 464 This is the first paper to establish the capacity of a rat epididymis-specific β-defensin, Bin1b, to promote the motility of immature sperm and sperm maturation, providing another example for the regulation of cell movement by defensins.
25. R. Palumbo, M. Sampaolesi, F. De Marchis, R. Tonlorenzi, S. Colombetti, A. Mondino, G. Cossu, and M.E. Bianchi Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation J Cell Biol 164 2004 441 449
26. R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, and C. Lebherz An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 111 2003 1665 1672 This is the first paper to show that cathelicidin has the capacity to stimulate endothelial cell proliferation, activation and in vivo angiogenesis through FPRL1.
27. B. Degryse, T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M.E. Bianchi The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 152 2001 1197 1206
28. D. Yang, O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, J. Shogan, M. Anderson, J.M. Schroder, J.M. Wang, and OM.Z. Howard β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525 528
29. A. Biragyn, M. Surenhu, D. Yang, P.A. Ruffini, B.A. Haines, E. Klyushnenkova, J.J. Oppenheim, and L.W. Kwak Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens J Immunol 167 2001 6644 6653
30. F. Niyonsaba, K. Iwabuchi, H. Matsuda, H. Ogawa, and I. Nagaoka Epithelial cell-derived human β-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway Int Immunol 14 2002 421 426
31. F. Niyonsaba, H. Ogawa, and I. Nagaoka Human β-defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils Immunology 111 2004 273 281
32. J.R. Garcia, F. Jaumann, S. Schulz, A. Krause, J. Rodriguez-Jimenez, U. Forssmann, K. Adermann, E. Kluver, C. Vogelmeier, and D. Becker Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction Cell Tissue Res 306 2001 257 264
33. J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, E. Kang, A. Mohamed-Hadley, R.J. Buckanovich, D.O. Holtz, A. Jenkins, H. Na, and L. Zhang Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A Nat Med 10 2004 950 958 This is the first paper demonstrating that β-defensin-29 uses CCR6 to recruit dendritic cell (DC) precursors and DCs, which, under the influence of vascular endothelial growth factor-A in a tumor microenvironment, come to resemble endothelial cells and promote tumor-associated angiogenesis.
34. K. Kurosaka, Q. Chen, F. Yarovinsky, J.J. Oppenheim, and D. Yang Mouse cathelin-related antimicrobial peptide (CRAMP) chemoattracts leukocytes using FPRL1/mFPR2 as the receptor and acts as an immune adjuvant J Immunol 174 2005 6257 6265 Mouse cathelicidin/CRAMP chemoattracted phagocytes using mFPR2 and promoted ovalbumin-specific immune responses, demonstrating for the first time that cathelicidin has immunoenhancing effect in vivo.
35. D. Yang, H.F. Rosenberg, Q. Chen, K.D. Dyer, K. Kurosaka, and J.J. Oppenheim Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells Blood 102 2003 3396 3403 This is the initial report, documenting the identification of the chemoattracting activity of eosinophil-derived neurotoxin (EDN) for dendritic cells.
36. A. Rouhiainen, J. Kuja-Panula, E. Wilkman, J. Pakkanen, J. Stenfors, R.K. Tuominen, M. Lepantalo, O. Carpen, J. Parkkinen, and H. Rauvala Regulation of monocyte migration by amphoterin (HMGB1) Blood 104 2004 1174 1182 This is the first paper to describe the participation of high mobility group box protein 1 (HMGB1) and receptor for advanced glycation end products (RAGE) in the transendothelial migration of monocytes.
37. A. Biragyn, P.A. Ruffini, C.A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A.K. Shirakawa, J.M. Farber, D.M. Segal, and J.J. Oppenheim Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2 Science 298 2002 1025 1029
38. D.M. Bowdish, D.J. Davidson, D.P. Speert, and R.E. Hancock The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes J Immunol 172 2004 3758 3765
39. D.J. Davidson, A.J. Currie, G.S. Reid, D.M. Bowdish, K.L. MacDonald, R.C. Ma, R.E. Hancock, and D.P. Speert The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization J Immunol 172 2004 1146 1156 The first report demonstrating that human cathelicidin/LL-37 promotes the differentiation of monocytes into dendritic cells with increased endocytic capacity, co-stimulatory molecule expression, and secretion of Th1-inducing cytokines in vitro.
40. ••].
41. A. Elssner, M. Duncan, M. Gavrilin, and M.D. Wewers A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release J Immunol 172 2004 4987 4994
42. G.S. Tjabringa, J. Aarbiou, D.K. Ninaber, J.W. Drijfhout, O.E. Sorensen, N. Borregaard, K.F. Rabe, and P.S. Hiemstra The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor J Immunol 171 2003 6690 6696
43. Y.E. Lau, A. Rozek, M.G. Scott, D.L. Goosney, D.J. Davidson, and R.E. Hancock Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells Infect Immun 73 2005 583 591 The authors showed that human lung epithelial cells possess both high- and low-affinity binding sites for human cathelicidin/LL-37, providing the first indication that cathelicidin might interact with more than one receptor on epithelial cells.
44. J.S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377
45. -/- mice, the authors demonstrated, for the first time, that high mobility group box protein 1 (HMGB1) activation of mouse macrophages is predominantly mediated by RAGE.
46. A. Biragyn, P.A. Ruffini, M. Coscia, L.K. Harvey, S.S. Neelapu, S. Baskar, J.M. Wang, and L.W. Kwak Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo Blood 104 2004 1961 1969 This paper is the first report to show that mouse β-defensin 2 (mBD2) -target-antigen and mCCL20/MIP3α-target-antigen fusion products promoted the uptake, processing, and presentation of the target antigen to CD4 T cells via a CCR6-mediated sorting of target antigen into the MHC class II pathway, resulting in the augmentation of antigen-specific immune response.
47. G. Dranoff GM-CSF-based cancer vaccines Immunol Rev 188 2002 147 154
48. M.H. Manjili, X.Y. Wang, I.J. MacDonald, H. Arnouk, G.Y. Yang, M.T. Pritchard, and J.R. Subjeck Cancer immunotherapy and heat-shock proteins: promises and challenges Expert Opin Biol Ther 4 2004 363 373
49. A. Soruri, J. Riggert, T. Schlott, Z. Kiafard, C. Dettmer, and J. Zwirner Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNFα and prostaglandin E2-dependent mechanisms J Immunol 171 2003 2631 2636
50. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
51. B. Molon, G. Gri, M. Bettella, C. Gomez-Mouton, A. Lanzavecchia, A.C. Martinez, S. Manes, and A. Viola T cell costimulation by chemokine receptors Nat Immunol 6 2005 465 471 In this paper, the authors reported the recruitment of T cell CCR5 to the immunological synapse during APC-T cell interaction, presumably by APC-derived CCL5/RANTES, which prolongs/stabilizes APC-T cell interaction and enhances subsequent T cell activation.
52. B.J. Marsland, P. Battig, M. Bauer, C. Ruedl, U. Lassing, R.R. Beerli, K. Dietmeier, L. Ivanova, T. Pfister, and L. Vogt CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells Immunity 22 2005 493 505 The authors identified CCL19/ELC as an inducer of T cell proliferation in a DC-T co-culture system using a novel expression cloning technique, and subsequently established that both CCL19/ELC and CCL21/SLC, two chemokines using the same receptor CCR7, act as inducers of DC maturation for the promotion of T cell proliferation and activation.
53. A. Deng, S. Chen, Q. Li, S.C. Lyu, C. Clayberger, and A.M. Krensky Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator J Immunol 174 2005 5243 5248 This is the first report demonstrating the chemotactic and activating effects of granulysin on diverse subpopulations of human leukocytes.